The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases

This study aimed to prove that the FibroScan-aspartate aminotransferase (FAST) scores can be used to stratify disease severity in a Japanese cohort with fatty liver diseases [metabolic dysfunction-associated fatty liver disease (MAFLD) and nonalcoholic fatty liver disease (NAFLD)]. All the participa...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Hideki, Fukumoto, Shinya, Enomoto, Masaru, Uchida-Kobayashi, Sawako, Kimura, Tatsuo, Tamori, Akihiro, Nadatani, Yuji, Takashima, Shingo, Nishimoto, Naoki, Kawada, Norifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257719/
https://www.ncbi.nlm.nih.gov/pubmed/34226630
http://dx.doi.org/10.1038/s41598-021-93435-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257719/
https://www.ncbi.nlm.nih.gov/pubmed/34226630
http://dx.doi.org/10.1038/s41598-021-93435-x

Ejemplares similares